Machina Capital S.A.S. Sells 5,592 Shares of AMETEK, Inc. $AME

Machina Capital S.A.S. lessened its holdings in shares of AMETEK, Inc. (NYSE:AME) by 18.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 24,365 shares of the technology company’s stock after selling 5,592 shares during the period. AMETEK comprises approximately 0.8% of Machina Capital S.A.S.’s investment portfolio, making the stock its 26th biggest position. Machina Capital S.A.S.’s holdings in AMETEK were worth $4,581,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of AME. Darwin Wealth Management LLC bought a new position in AMETEK in the 2nd quarter worth about $25,000. TruNorth Capital Management LLC purchased a new stake in shares of AMETEK in the third quarter valued at approximately $31,000. NewSquare Capital LLC grew its stake in AMETEK by 129.7% in the second quarter. NewSquare Capital LLC now owns 170 shares of the technology company’s stock worth $31,000 after purchasing an additional 96 shares in the last quarter. SouthState Corp increased its holdings in AMETEK by 47.4% during the 2nd quarter. SouthState Corp now owns 202 shares of the technology company’s stock worth $37,000 after purchasing an additional 65 shares during the period. Finally, Grey Fox Wealth Advisors LLC bought a new stake in AMETEK during the 3rd quarter valued at $39,000. 87.43% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. Morgan Stanley boosted their price target on shares of AMETEK from $198.00 to $215.00 and gave the company an “equal weight” rating in a report on Monday, January 12th. Wall Street Zen raised shares of AMETEK from a “hold” rating to a “buy” rating in a research note on Saturday, November 1st. Mizuho upped their target price on AMETEK from $225.00 to $230.00 and gave the stock an “outperform” rating in a report on Monday, January 5th. Melius Research set a $235.00 price target on AMETEK in a report on Monday, January 5th. Finally, DA Davidson upped their price objective on AMETEK from $235.00 to $240.00 and gave the stock a “buy” rating in a research note on Monday, December 8th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $229.82.

Insiders Place Their Bets

In related news, VP Thomas M. Montgomery sold 6,388 shares of AMETEK stock in a transaction dated Monday, December 22nd. The stock was sold at an average price of $205.05, for a total transaction of $1,309,859.40. Following the completion of the sale, the vice president owned 22,116 shares of the company’s stock, valued at $4,534,885.80. The trade was a 22.41% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO David A. Zapico sold 28,390 shares of the company’s stock in a transaction that occurred on Friday, December 12th. The shares were sold at an average price of $201.76, for a total value of $5,727,966.40. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 137,088 shares of company stock valued at $27,212,340. 0.57% of the stock is owned by company insiders.

More AMETEK News

Here are the key news stories impacting AMETEK this week:

• Positive Sentiment: Beat Q4 estimates and reported record revenue — AMETEK posted $2.01 EPS (vs. ~$1.94 est.) and ~$2.0B in revenue, with revenue up ~13% year‑over‑year and healthy margins, driving the positive market reaction. AMETEK Announces Record Fourth Quarter and Full Year Results
• Positive Sentiment: Strong profitability metrics — management reported a ~20.5% net margin and solid ROE, supporting the narrative of durable margins even as revenue grows. Listen to Conference Call / Press Release
• Positive Sentiment: Acquisition adds to medical/ophthalmic portfolio — AMETEK agreed to buy LKC Technologies, expanding its position in diagnostics/ophthalmic test equipment, a strategic tuck‑in likely to support long‑term growth. AMETEK Acquires LKC Technologies
• Neutral Sentiment: 2026 guidance set but conservatively framed — AMETEK gave FY2026 EPS guidance of $7.870–8.070 and Q1 EPS of $1.850–1.900; the ranges are close to Street forecasts but leave limited upside, so the guidance is more stabilizing than bullish. AMETEK Delivers Record 2025 Results and Confident 2026 Outlook
• Neutral Sentiment: Management commentary and call transcript available — investors can review the earnings call for details on end‑market trends (process markets showing signs of life) and margin drivers to judge sustainability. Q4 2025 Earnings Call Transcript
• Negative Sentiment: Guidance flagged tariff uncertainty — management noted tariff-related risk that contributed to a FY guide slightly below consensus, which could cap near‑term multiple expansion if trade/tariff risks persist. AMETEK forecasts 2026 profit below estimates on tariff uncertainty
• Negative Sentiment: Some investors trimming positions on valuation — at least one manager reduced exposure citing valuation, a reminder that AME’s premium multiple leaves it sensitive to guidance disappointments. Giverny Capital Asset Management Trimmed Ametek (AME) on Valuation

AMETEK Trading Up 0.4%

AMETEK stock opened at $228.68 on Wednesday. The company has a debt-to-equity ratio of 0.14, a quick ratio of 0.72 and a current ratio of 1.16. The stock has a market cap of $52.64 billion, a PE ratio of 36.07, a price-to-earnings-growth ratio of 3.10 and a beta of 1.03. The stock has a 50-day moving average of $209.02 and a two-hundred day moving average of $194.83. AMETEK, Inc. has a one year low of $145.02 and a one year high of $233.17.

AMETEK (NYSE:AME) last issued its quarterly earnings results on Tuesday, February 3rd. The technology company reported $2.01 earnings per share for the quarter, topping analysts’ consensus estimates of $1.94 by $0.07. The business had revenue of $2 billion for the quarter, compared to analyst estimates of $1.94 billion. AMETEK had a return on equity of 16.66% and a net margin of 20.50%.The company’s revenue was up 13.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.87 earnings per share. AMETEK has set its Q1 2026 guidance at 1.850-1.900 EPS and its FY 2026 guidance at 7.870-8.070 EPS. On average, research analysts anticipate that AMETEK, Inc. will post 7.15 EPS for the current fiscal year.

AMETEK Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, December 19th. Investors of record on Friday, December 5th were paid a $0.31 dividend. The ex-dividend date was Friday, December 5th. This represents a $1.24 dividend on an annualized basis and a yield of 0.5%. AMETEK’s dividend payout ratio (DPR) is 19.56%.

AMETEK Profile

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.